• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by SNDL Inc. (Amendment)

    2/14/23 5:28:02 PM ET
    $SNDL
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $SNDL alert in real time by email
    SC 13G/A 1 ea173608-13ga4etf_sundial.htm AMENDMENT NO. 4 TO SCHEDULE 13G

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

     

    (Amendment No. 4 )*

     

    Sundial Growers Inc.
    (Name of Issuer)
     
    Common Stock, $0.001 Par Value Per Share
    (Title of Class of Securities)
     
    83307B101
    (CUSIP Number)
     
    December 31, 2022
    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☒ Rule 13d-1(b)

     

    ☐ Rule 13d-1(c)

     

    ☐ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    SCHEDULE 13G

     

    CUSIP No.

    83307B101

     

    1 Names of Reporting Persons
    ETF Managers Group LLC
    2 Check the appropriate box if a member of a Group (see instructions)

    (a) ☐
    (b) ☒*

     

    * This filing describes the reporting person’s relationship with other persons, but the reporting person does not affirm the existence of a group.

    3

    Sec Use Only

     

    4 Citizenship or Place of Organization
    Delaware

    Number of
    Shares Beneficially
    Owned by Each
    Reporting Person With:

     

    5 Sole Voting Power
    12,488,306
    6 Shared Voting Power
     
    7 Sole Dispositive Power
    12,488,306
    8 Shared Dispositive Power
     
    9 Aggregate Amount Beneficially Owned by Each Reporting Person
    12,488,306
    10 Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
    ☐
    11 Percent of class represented by amount in row (9)
    5.28%
    12 Type of Reporting Person (See Instructions)
    IA

    Page 2 of 5

     

     

    Item 1.

     

    (a)Name of Issuer: Sundial Growers Inc.

     

    (b)Address of Issuer’s Principal Executive Offices: #300, 919 - 11 AVENUE SW CALGARY, AB T2R 1P3

     

    Item 2.

     

    (a)Name of Person Filing: ETF Managers Group LLC

     

    (b)Address of Principal Business Office or, if None, Residence:

     

    ETF Managers Group LLC - 30 Maple Street, Suite 2, Summit, New Jersey 07091

     

    (c)Citizenship: ETF Managers Group LLC – Delaware

     

    (d)Title and Class of Securities: Common Stock

     

    (e)CUSIP No.: 83307B101

     

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)☐  Broker or dealer registered under Section 15 of the Act;

     

    (b)☐  Bank as defined in Section 3(a)(6) of the Act;

     

    (c)☐  Insurance company as defined in Section 3(a)(19) of the Act;

     

    (d)☐  Investment company registered under Section 8 of the Investment Company Act of 1940;

     

    (e)☒  An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

     

    (f)☐  An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

     

    (g)☐  A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

     

    (h)☐  A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    (i)☐  A church plan that is excluded from the definition of an investment company under section 3(c)(14) of  the Investment Company Act of 1940;

     

    (j)☐  A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);

     

    (k)☐  Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

     

    Page 3 of 5

     

     

    Item 4.Ownership

     

    (a)Amount Beneficially Owned: 12,488,306

     

    (b)Percent of Class: 5.28%

     

    (c)Number of shares as to which such person(s) has:

     

    (i)Sole power to vote or to direct the vote:   12,488,306

     

    (ii)Shared power to vote or to direct the vote:

     

    (iii)Sole power to dispose or to direct the disposition of:   12,488,306

     

    (iv)Shared power to dispose or to direct the disposition of:

     

    Item 5.Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

     

    Item 6.Ownership of more than Five Percent on Behalf of Another Person.

     

    ETF Managers Group, LLC (“ETFMG”), is filing as an investment adviser in accordance with 240.13d-1(b)(1)(ii)(E). Various advisory clients of ETFMG have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of the Issuer. The interest of one such client, the ETFMG Alternative Harvest ETF, a series of the ETF Managers Trust, exceeds five percent of the total outstanding common shares. These shares were acquired in the ordinary course of business, and not with the purpose or effect of changing or influencing control of the Issuer. No other advisory client interest relates to more than five percent of the class.

     

    Item 7.Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company or control person.

     

    Not Applicable

     

    Item 8.Identification and classification of members of the group.

     

    Not Applicable.

     

    Item 9.Notice of Dissolution of Group.

     

    Not Applicable

     

    Item 10.Certifications.

     

    By signing below, we certify that, to the best of our knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    Page 4 of 5

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct.

     

    Dated:  February 14, 2023  
       
    /s/ Matthew J. Bromberg  

    Name/Title: Matthew Bromberg,
    Chief Compliance Officer, ETF Managers Group LLC

     

     

     

    Page 5 of 5

     

     

    Get the next $SNDL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNDL

    DatePrice TargetRatingAnalyst
    7/17/2024Speculative Buy
    Canaccord Genuity
    8/16/2022$5.00Hold → Speculative Buy
    Canaccord Genuity
    5/3/2022$0.60 → $0.70Underperform → Market Perform
    BMO Capital Markets
    More analyst ratings

    $SNDL
    SEC Filings

    See more
    • SEC Form 6-K filed by SNDL Inc.

      6-K - SNDL Inc. (0001766600) (Filer)

      5/1/25 7:21:29 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by SNDL Inc.

      6-K - SNDL Inc. (0001766600) (Filer)

      4/30/25 7:55:52 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by SNDL Inc.

      6-K - SNDL Inc. (0001766600) (Filer)

      4/22/25 7:32:45 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Financials

    Live finance-specific insights

    See more
    • SNDL Reports First Quarter 2025 Financial and Operational Results

      The Company Delivers Record Gross Margin and Positive Cash Flow; Announces Strategic Review of U.S. Platform and Listing Structure EDMONTON, AB, May 1, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March 31, 2025. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com. The Company will hold a conference cal

      5/1/25 7:00:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL to Announce First Quarter 2025 Financial Results on May 1, 2025

      EDMONTON, AB, April 14, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL") announced today that it will release its first quarter 2025 financial results for the period ended March 31, 2025, before market opens on Thursday, May 1, 2025. Following the release of its first quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on May 1, 2025. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/4ikuz377 ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), th

      4/14/25 4:30:00 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL Reports Fourth Quarter and Full Year 2024 Financial and Operational Results

      The Company reports Record Full Year Net Revenue, Gross Profit and Gross Margin, as well as positive Cash Flow and Free Cash Flow  CALGARY, AB, March 18, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the full year and fourth quarter ended December 31, 2024. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation and shareholder letter on its website, found at https://sndl.com. The Co

      3/18/25 7:00:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SNDL Reports First Quarter 2025 Financial and Operational Results

      The Company Delivers Record Gross Margin and Positive Cash Flow; Announces Strategic Review of U.S. Platform and Listing Structure EDMONTON, AB, May 1, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL" or the "Company") reported its financial and operational results for the first quarter ended March 31, 2025. All financial information in this press release is reported in millions of Canadian dollars unless otherwise indicated. SNDL has also posted a supplemental investor presentation on its website, found at https://sndl.com. The Company will hold a conference cal

      5/1/25 7:00:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL Launches Rise Rewards Loyalty Program

      EDMONTON, AB, April 22, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL" or the "Company") is excited to announce the launch of its highly anticipated Rise Rewards loyalty program, designed to help Value Buds customers save more, earn more, and get even more from every visit. Starting April 22, 2025, Rise Rewards will be available at all Value Buds locations in Alberta, Ontario, Saskatchewan, and Manitoba. "Our vision is always focused on the consumer experience, and our Rise Rewards program is an exciting tool to provide even more value for the Value Buds shoppe

      4/22/25 7:00:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL to Announce First Quarter 2025 Financial Results on May 1, 2025

      EDMONTON, AB, April 14, 2025 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) (CSE:SNDL) ("SNDL") announced today that it will release its first quarter 2025 financial results for the period ended March 31, 2025, before market opens on Thursday, May 1, 2025. Following the release of its first quarter results, SNDL will host a conference call and webcast at 10:00 a.m. EDT (8:00 a.m. MDT) on May 1, 2025. WEBCAST ACCESS To access the live webcast of the call, please visit the following link: https://edge.media-server.com/mmc/p/4ikuz377 ABOUT SNDL INC.  SNDL Inc. (NASDAQ:SNDL, CSE:SNDL), th

      4/14/25 4:30:00 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Canaccord Genuity resumed coverage on SNDL Inc.

      Canaccord Genuity resumed coverage of SNDL Inc. with a rating of Speculative Buy

      7/17/24 12:19:57 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Sundial Growers upgraded by Canaccord Genuity with a new price target

      Canaccord Genuity upgraded Sundial Growers from Hold to Speculative Buy and set a new price target of $5.00

      8/16/22 7:59:34 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Sundial Growers upgraded by BMO Capital Markets with a new price target

      BMO Capital Markets upgraded Sundial Growers from Underperform to Market Perform and set a new price target of $0.70 from $0.60 previously

      5/3/22 7:19:03 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SNDL Inc. (Amendment)

      SC 13G/A - SNDL Inc. (0001766600) (Filed by)

      1/31/24 4:48:48 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by SNDL Inc. (Amendment)

      SC 13G/A - SNDL Inc. (0001766600) (Subject)

      2/14/23 5:28:02 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by SNDL Inc. (Amendment)

      SC 13G/A - SNDL Inc. (0001766600) (Filed by)

      2/13/23 4:06:09 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care

    $SNDL
    Leadership Updates

    Live Leadership Updates

    See more
    • SNDL Appoints New Chief Information Officer and New President, Liquor Division

      CALGARY, AB, Nov. 21, 2024 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") is pleased to announce the appointments of Phil McBride as Chief Information Officer and Navroop Sandhawalia as President, Liquor Division. "SNDL's success is driven by our commitment to talent density and our leaders are the foundation of our performance culture," said Zach George, Chief Executive Officer of SNDL.  "Phil's extensive expertise in technology and digital innovation, paired with Nav's financial acumen and best-in-class retail experience will further strengthen our executio

      11/21/24 6:02:00 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • SNDL Announces 2024 Annual General Meeting Results

      CALGARY, AB, July 30, 2024 /PRNewswire/ - SNDL Inc. (NASDAQ:SNDL) ("SNDL" or the "Company") is pleased to announce the resolutions put to holders of common shares (the "Shareholders") at the Annual General Meeting (the "Meeting") were passed. At the Meeting, Shareholders approved: (i) fixing the number of directors of the board at six (6); (ii) electing each of Gregory Mills, Zachary George, Lori Ell, Frank Krasovec, Bryan Pinney and Gregory Turnbull as directors of the Company for the ensuing year; and (iii) re-appointing Marcum LLP as the auditors of the Company for the ensu

      7/30/24 5:45:00 PM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care
    • Skymint Assets Acquired from Receivership; Sunstream USA Builds on Parallel Acquisition

      CALGARY, AB, Oct. 13, 2023 /PRNewswire/ - SunStream Bancorp Inc. ("SunStream") is pleased to announce a receivership court order (the "Sale Order") granting the sale of certain assets of Greenpeak Industries Inc. and certain affiliated entities d.b.a. Skymint ("Skymint") to Skymint Acquisition Co. (the "Skymint Transaction"), a newly formed designee entity of Tropics LP ("Tropics"). Tropics is a limited partnership fully owned by an affiliate of Sunstream, a joint venture sponsored by SNDL Inc. (NASDAQ:SNDL) ("SNDL").  Skymint Acquisition Co. is anticipated to be part of the S

      10/13/23 8:37:00 AM ET
      $SNDL
      Medicinal Chemicals and Botanical Products
      Health Care